First Drugs Chosen for Medicare Negotiations Hit Close to Ho

Optimism must be balanced with conservative expectations given the unknown nature of the cost impact, says Mary N. Walsh.

Related Keywords

France , White House , District Of Columbia , United States , Boehringer Ingelheim Eli Lilly , Bayer Janssen , Maryn Walsh , Bristol Myers Squibb , Abbvie Johnson , Astrazeneca , American College Of Cardiology , Amgen , Novo Nordisk , Vincent Heart Center , Johnson , Novartis , Inflation Reduction Act , Eli Lilly , American College ,